• American Medical Directors Association (AMDA). Anemia in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2007. 28 p. [65 references]

This is the current release of the guideline.

The type of evidence supporting the recommendations is not specifically stated.

The guideline was developed by an interdisciplinary work group using a process that combined evidence- and consensus-based thinking.

• American Medical Directors Association (AMDA). Anemia in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2007. 28 p. [65 references]

Not applicable: The guideline was not adapted from another source.

2007

American Medical Directors Association - Professional Association

Organizational participants included:

• American Association of Homes and Services for the Aging
• American College of Health Care Administrators
• American Geriatrics Society
• American Health Care Association
• American Society of Consultant Pharmacists
• National Association of Directors of Nursing Administration in Long-Term Care
• National Association of Geriatric Nursing Assistants
• National Conference of Gerontological Nurse Practitioners

Funding was supported by the following: Amgen, Merck & Co., Inc., Ross Products Division of Abbott Laboratories, Sanofi-Aventis

Steering Committee

Committee Members: Marjorie Berleth, MSHA RNC FADONA; Lisa Cantrell, RN, C; Sandra Fitzler, RN; Joseph Gruber, RPh, FASCP, CGP; Hosam Kamel, MD, CMD; Susan M. Levy, MD, CMD; Harlan Martin, R.Ph., CCP, FASCP; Evvie F. Munley; Jonathan Musher, MD, CMD; Barbara Resnick, PhD, CRNP; William Simonson, Pharm.D., FASCP

Not stated

This is the current release of the guideline.

None available

None available

This summary was completed by ECRI Institute on July 9, 2007. The information was verified by the guideline developer on August 23, 2007. This summary was updated by ECRI Institute on March 21, 2008 following the FDA advisory on Erythropoiesis Stimulating Agents. This summary was updated by ECRI Institute on August 15, 2008 following the U.S. Food and Drug Administration advisory on Erythropoiesis Stimulating Agents (ESAs).

This NGC summary is based on the original guideline, which is copyrighted by the American Medical Directors Association (AMDA). Written permission from AMDA must be obtained to duplicate or disseminate information from the original guideline. For more information, contact AMDA at (410) 740-9743.